Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Association between Calcineurin Inhibitor Blood Concentrations and Outcomes after Allogeneic Hematopoietic Cell Transplantation

Published:2012-03 Issue:3 Volume:18 Page:414-422
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ram Ron,Storer Barry,Mielcarek Marco,Sandmaier Brenda M.,Maloney David G.,Martin Paul J.,Flowers Mary E.D.,Chua Bee K.,Rotta Marcello,Storb Rainer

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Manifestations and treatment of acute graft-versus-host disease;Cutler,2009

2. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia;Gratwohl;Blood,1995

3. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease;Storb;Blood,1986

4. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia;Storb;N Engl J Med,1986

5. Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host-disease prophylaxis after HLA-identical sibling bone marrow transplantation;Ratanatharathorn;Blood,1998

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion;Cytotherapy;2024-05

2. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation;The Lancet Haematology;2024-02

3. A dynamic time‐to‐event model for prediction of acute graft‐versus‐host disease in patients after allogeneic hematopoietic stem cell transplantation;Cancer Medicine;2023-12-22

4. Post transplant Immunosuppression;Basics of Hematopoietic Stem Cell Transplant;2023

5. Toward optimization of cyclosporine concentration target to prevent acute graft‐versus‐host disease following myeloablative allogeneic stem cell transplant;Clinical Transplantation;2022-06-02